VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.02 Cr | ₹-1.08 Cr | ₹-0.57 Cr | ₹-9.48 Cr | ₹-162 Cr |
What is the latest Cash Flow from Financing Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.02 Cr |
| Mar2024 | ₹-1.08 Cr |
| Mar2023 | ₹-0.57 Cr |
| Mar2022 | ₹-9.48 Cr |
| Mar2021 | ₹-162 Cr |
How is Cash Flow from Financing Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.02 Cr | Negative | |
| Mar2024 | ₹-1.08 Cr | Negative | |
| Mar2023 | ₹-0.57 Cr | Negative | |
| Mar2022 | ₹-9.48 Cr | Negative | |
| Mar2021 | ₹-162 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,283.2 Cr | -3.5% | 1% | 285.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -3.5% |
1% |
285.9% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses